BHC.TO Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 13:43):

Stats
Today's Volume	179 339
Average Volume	367 943
Market Cap	4.34B
EPS	$0 ( 2024-02-21 )
Next earnings date	( $0.940 ) 2024-05-01
Last Dividend	$0.0970 ( 2010-08-30 )
Next Dividend	$0 ( N/A )
P/E	-5.33
ATR14	$0.00900 (0.08%)

Volume Correlation

Long: -0.15 (neutral)

Short: -0.58 (weak negative)

Signal:(59.317) Neutral

BAUSCH HEALTH COMPANIES Correlation

10 Most Positive Correlations
HOM-UN.TO	0.907
CJR-B.TO	0.898
MTY.TO	0.893
GOOS.TO	0.885
ERO.TO	0.882
LUN.TO	0.88
LB.TO	0.877
CARS.TO	0.875
IGM.TO	0.872
D-UN.TO	0.871

10 Most Negative Correlations
QBTL.TO	-0.877
UNS.TO	-0.87
SBB.TO	-0.855
E.TO	-0.844
ABCT.TO	-0.836
SFC.TO	-0.822
THNC.TO	-0.822

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BAUSCH HEALTH COMPANIES Correlation - Currency/Commodity

0.03
( neutral )

0.12
( neutral )

0.00
( neutral )

-0.66
( moderate negative )

0.23
( neutral )

BAUSCH HEALTH COMPANIES Financials

Annual	2023
Revenue:	$8.76B
Gross Profit:	$6.20B (70.78 %)
EPS:	$-1.620

Q4	2023
Revenue:	$2.41B
Gross Profit:	$1.70B (70.72 %)
EPS:	$-0.110

Q3	2023
Revenue:	$2.24B
Gross Profit:	$1.62B (72.16 %)
EPS:	$-1.030

Q2	2023
Revenue:	$2.17B
Gross Profit:	$1.52B (70.05 %)
EPS:	$0.0700

Financial Reports:

No articles found.

BAUSCH HEALTH COMPANIES Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BAUSCH HEALTH COMPANIES Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.74 - low (57.34%) | Divividend Growth Potential Score: 3.23 - No dividend growth expected in the near future

Information

First Dividend	$0.598	2005-11-28
Last Dividend	$0.0970	2010-08-30
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	20	--
Total Paid Out	$5.49	--
Avg. Dividend % Per Year	0.00%	--
Score	2.89	--
Div. Sustainability Score	4.74
Div.Growth Potential Score	3.23
Div. Directional Score	3.98	--

Next Divdend (Est)
(2024-04-29)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.89

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for TSX

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
VXC.TO	Dividend Junior	2023-06-30	Quarterly	11	0.89%
NWC.TO	Dividend King	2023-06-29	Quarterly	23	2.37%
DXW.TO	Dividend Junior	2023-07-25	Bi-Monthly	5	1.12%
ZEQ.TO	Dividend Junior	2023-06-28	Quarterly	11	1.20%
SSRM.TO	Dividend Junior	2023-08-11	Quarterly	4	0.61%
HUBL.TO	Dividend Knight	2023-08-30	Monthly	7	3.76%
CDZ.TO	Dividend Knight	2023-07-25	Monthly	19	2.10%
XDU.TO	Dividend Knight	2023-08-25	Monthly	8	1.42%
PKI.TO	Dividend King	2023-09-21	Bi-Monthly	29	2.24%
FAP.TO	Ex Dividend Knight	2023-09-21	Annually	29	0.09%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0685	1.500	-1.370	-2.06	[0 - 0.5]
returnOnAssetsTTM	-0.0219	1.200	-0.731	-0.878	[0 - 0.3]
returnOnEquityTTM	0.618	1.500	4.24	6.36	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.301	0.800	8.50	6.80	[1 - 3]
quickRatioTTM	0.685	0.800	-0.679	-0.543	[0.8 - 2.5]
cashRatioTTM	0.220	1.500	9.89	10.00	[0.2 - 2]
debtRatioTTM	0.819	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0.725	1.000	-0.843	-0.843	[3 - 30]
operatingCashFlowPerShareTTM	3.09	2.00	8.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.30	2.00	8.85	10.00	[0 - 20]
debtEquityRatioTTM	-21.91	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.708	1.000	1.537	1.537	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0489	1.000	-0.839	-0.839	[0.2 - 2]
assetTurnoverTTM	0.320	0.800	-1.199	-0.959	[0.5 - 2]
Total Score				4.74

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.27	1.000	-0.633	0	[1 - 100]
returnOnEquityTTM	0.618	2.50	6.30	6.36	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.30	2.00	9.23	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.09	2.00	8.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.147	1.500	-4.31	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.125	1.000	9.37	0	[0.1 - 0.5]
Total Score				3.23

BAUSCH HEALTH COMPANIES

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.